Science now seems close to winning the war against AIDS, as FDA approves of a new drug which has a different course of action as compared to the already existing ones. The new drug, known as 'Isentress' acts upon the HIV virus in a different manner...
Statement by Dr. John Mellors who is chief of infectious diseases at the University of Pittsburgh that about half of U.S. patients treated for infections with HIV have stopped responding to at least one drug is enough to give us a reason to rethink that...
Tags:
HIV, AIDS, Resistance to HIV drugs, Resistance to AIDS drugs, MK-0518, Integrase inhibitor, GS-9137, CCR5 inhibitors, Maraviroc, Prezista, Transcriptase inhibitor, TMC278, Health & Fitness
Fresh Comments